Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINJECTIONStandard

XIAFLEX

COLLAGENASE CLOSTRIDIUM HISTOLYTICUM

Standard Dose
0.9MG
Max Dose
Refer to approved labeling
Primary Use
Review priority: N/A Marketing status: Prescription
Summary

Approval overview XIAFLEX is listed in Drugs@FDA under application 125338 (BLA).

Review priority: N/A Marketing status: Prescription Active ingredient COLLAGENASE CLOSTRIDIUM HISTOLYTICUM Form and strength SOLUTION; INJECTION - 0.9MG Sponsor AUXILIUM PHARMS Submission history Latest submission status date: 2024-10-11 00:00:00.

Structured Monograph

Clinical summary

Approval overview XIAFLEX is listed in Drugs@FDA under application 125338 (BLA). Review priority: N/A Marketing status: Prescription Active ingredient COLLAGENASE CLOSTRIDIUM HISTOLYTICUM Form and strength SOLUTION; INJECTION - 0.9MG Sponsor AUXILIUM PHARMS Submission history Latest submission status date: 2024-10-11 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Prescription
  • • Review priority: N/A

Interaction Notes

  • No interaction notes stored yet.